2020-03-26 |
1 |
Complaint |
United States Patent Nos. 7,045,620 (the
“’620 patent”); 7,612,199 (the “’199 patent”); 7,902,206 (the…infringed one or more claims of United States Patent
Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,644…infringe one or more claims of
United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 8,158,… C. A judgment that United States Patent Nos. 7,045,620; 7,612,199; 7,902,206;
7,906,542; 8,158,644…to
the expiration date of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542;
8,158,644 |
External link to document |
2021-08-03 |
118 |
|
the Invalidity of U.S. Patent Nos. 8,642,573; 8,969,398; 9,421,195; 10,335,397; and 10,709,694 4. Opening…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 2. Opening Expert of Michael J. Zaworotko…Zaworotko, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542… 25 September 2020
1:19-cv-00734
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2021-10-19 |
138 |
|
Ph.D. Regarding the Invalidity of U.S. Patent Nos. 7,045,620; 7,612,199; 7,902,206; and 7,906,542 (3)…Bergstrom, Ph.D. Regarding the Invalidity of U.S. Patent No. 7,906,542 (7) Responsive Expert Report of Richard…Regarding Noninfringement of Claims 9 and 10 of U.S. Patent No. 7,906,542 filed by Norwich Pharmaceuticals … 25 September 2020
1:19-cv-00734
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2020-03-26 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,045,620 ;7,612,199 ;7,902,206… 25 September 2020
1:19-cv-00734
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2020-11-12 |
60 |
Appendix |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,045,620; 7,612,199; 7,902,… 25 September 2020
1:19-cv-00734
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2020-09-25 |
70 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,045,620; 7,612,199; 7,902,206… 25 September 2020
1:19-cv-00734
835 Patent - Abbreviated New Drug Application(ANDA)
Both |
External link to document |
2021-02-09 |
76 |
|
9,629,828; 10,314,828; 10,335,397; and 10,456,384; On or about October 6, 2020 for Patent Numbers 10,…9,421,195; 9,629,828; 10,314,828; 10,335,397; 10,709,694; October 2, 2029 for Patent Nos. 8,642,573; 8,969,398… 2020 for Patent Number 10,765,667.. Date of Expiration of Patent: June 19, 2024 for Patent Nos. 7,045,620…for Patent No. 7,906,542; February 23, 2025 for Patent No. 7,915,275; February 27, 2026 for Patent Nos…10,703,763; September 2, 2027 for Patent No. 8,193,196; February 26, 2029 for Patent Nos. 10,456,384; 10,765,667 |
External link to document |